May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Effects of Latanoprost 0.005% and Timolol 0.5% Gel-forming Solution on Diurnal Intraocular Pressure Curve in Japanese Normal-tension Glaucoma
Author Affiliations & Notes
  • Y. Tamada
    Ophthalmology, Gifu Univ Sch of Med, Gifu-shi, Japan
  • M. Sato
    Ophthalmology, Gifu Univ Sch of Med, Gifu-shi, Japan
  • K. Sugiyama
    Ophthalmology, Kanazawa Univ Graduate Sch of Med, Kanazawa-shi, Japan
  • K. Kawase
    Ophthalmology, Kanazawa Univ Graduate Sch of Med, Kanazawa-shi, Japan
  • T. Yamamoto
    Ophthalmology, Kanazawa Univ Graduate Sch of Med, Kanazawa-shi, Japan
  • Footnotes
    Commercial Relationships  Y. Tamada, None; M. Sato, None; K. Sugiyama, None; K. Kawase, None; T. Yamamoto, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 122. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Y. Tamada, M. Sato, K. Sugiyama, K. Kawase, T. Yamamoto; Effects of Latanoprost 0.005% and Timolol 0.5% Gel-forming Solution on Diurnal Intraocular Pressure Curve in Japanese Normal-tension Glaucoma . Invest. Ophthalmol. Vis. Sci. 2003;44(13):122.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To prospectively compare the effect of latanoprost 0.005% and timolol 0.5% gel-forming solution on the diurnal intraocular pressure. Methods: Thirty eyes of 30 normal-tension glaucoma patients were enrolled (12 men and 18 women; mean age 53.7±14.6 years). After four-week wash-out of glaucoma medication, patients were randomly assigned to treat either with latanoprost 0.005% once daily or timolol 0.5% gel-forming solution once daily. Diurnal IOP was measured every two hours by one investigator with the same Goldmann applanation tonometer on day 0 without medication, on day 2 with medication. Ocular hypotensive effect was analyzed regarding IOP, DIOP (without medication – with medication) and the area under the curve (AUC). The AUC was divided into daytime (from 6 a.m. to 6 p.m.) and nighttime (from 6 p.m. to 6 a.m.). Results: The mean diurnal IOP without medication were 12.6 ± 1.9 mmHg in the Latanoprost group and 12.8 ± 1.9 mmHg in the Timorlol group (mean ± SD). The Latanoprost group showed significant IOP-lowering effect throughout 24 hours (DIOP; 1.4~2.2mmHg). On the other hand, the timolol group did not show significant IOP-lowering effect during nighttime (0~6 a.m.). The Latanoprost group showed no difference between daytime AUC and nighttime AUC. The daytime AUC was significantly larger than the nighttime AUC in the Timolol group. Conclusion: Both latanoprost 0.005% and timolol 0.5% gel-forming solution had significant ocular hypotensive effect in Japanese normal-tension glaucoma patients. Latanoprost 0.005% showed significant IOP-lowering effect throughout 24 hours. Ocular hypotensive effect of nighttime of timolol 0.5% gel-forming solution was less than that of daytime. CR: None

Keywords: intraocular pressure • drug toxicity/drug effects • outflow: trabecular meshwork 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×